Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
CASI Pharmaceuticals
About
CASI focus on building a pipeline through mutually beneficial business development transactions.
- 101 - 250
Highlights
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $50M
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 1991
- Number Of Employee
- 101 - 250
- Operating Status
- Active
CASI Pharmaceuticals, Inc. ("CASI", "we" or "us") is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. CASI is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. CASI is executing its plan to become a biopharmaceutical leader by launching medicines in the greater China market leveraging CASI's China-based regulatory and commercial competencies and its global drug development expertise.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 20, 2018 | Post-IPO Equity | $50M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Post-IPO Equity |
